| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review
|
Lens, M.B.
|
|
|
16 |
3 |
p. 460-465
|
artikel
|
| 2 |
Avoiding axillary dissection in breast cancer surgery: a randomized trial to assess the role of axillary radiotherapy
|
Veronesi, U.
|
|
|
16 |
3 |
p. 383-388
|
artikel
|
| 3 |
Biology and Management of Multiple Myeloma
|
Jacobs, P.
|
|
|
16 |
3 |
p. 519
|
artikel
|
| 4 |
Cancer incidence and mortality in Europe, 2004
|
Boyle, P.
|
|
|
16 |
3 |
p. 481-488
|
artikel
|
| 5 |
Can HER2 overexpression predict response to pegylated liposomal doxorubicin in metastatic breast cancer patients?
|
Fabi, A.
|
|
|
16 |
3 |
p. 516-517
|
artikel
|
| 6 |
Central nervous system involvement in indolent lymphomas
|
Spectre, G.
|
|
|
16 |
3 |
p. 450-454
|
artikel
|
| 7 |
Chemotherapy options and new advances in malignant pleural mesothelioma
|
Steele, J.P.C.
|
|
|
16 |
3 |
p. 345-351
|
artikel
|
| 8 |
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741
|
Delaunoit, T.
|
|
|
16 |
3 |
p. 425-429
|
artikel
|
| 9 |
Course of mental fatigue and motivation in breast cancer patients receiving adjuvant chemotherapy
|
de Jong, N.
|
|
|
16 |
3 |
p. 372-382
|
artikel
|
| 10 |
Expression of survivin and bax/bcl-2 in peroxisome proliferator activated receptor-γ ligands induces apoptosis on human myeloid leukemia cells in vitro
|
Liu, J.J.
|
|
|
16 |
3 |
p. 455-459
|
artikel
|
| 11 |
FDG-PET scanning for detection and staging of extranodal marginal zone lymphomas of the MALT type: a report of 42 cases
|
Beal, K.P.
|
|
|
16 |
3 |
p. 473-480
|
artikel
|
| 12 |
Fludarabine: risk factor for aggressive behaviour of squamous cell carcinoma of the skin?
|
Herr, D.
|
|
|
16 |
3 |
p. 515-516
|
artikel
|
| 13 |
High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma
|
Jahnke, K.
|
|
|
16 |
3 |
p. 445-449
|
artikel
|
| 14 |
How little is known about cervical cancer in pregnancy?
|
Sadler, L.
|
|
|
16 |
3 |
p. 341-343
|
artikel
|
| 15 |
Laparoscopic management of borderline ovarian tumors: results of a French multicenter study
|
Fauvet, R.
|
|
|
16 |
3 |
p. 403-410
|
artikel
|
| 16 |
Long-term follow-up of a randomized trial of fludarabine–mitoxantrone, compared with cyclophosphamide, doxorubicin, vindesine, prednisone (CHVP), as first-line treatment of elderly patients with advanced, low-grade non-Hodgkin's lymphoma before the era of monoclonal antibodies
|
Foussard, C.
|
|
|
16 |
3 |
p. 466-472
|
artikel
|
| 17 |
Management and clinical outcomes of pregnant patients with invasive cervical cancer
|
Germann, N.
|
|
|
16 |
3 |
p. 397-402
|
artikel
|
| 18 |
Natural medicine: a ‘new frontier’ in oncology?
|
Marchetti, Paolo
|
|
|
16 |
3 |
p. 339-340
|
artikel
|
| 19 |
Oleic acid, the main monounsaturated fatty acid of olive oil, suppresses Her-2/neu (erbB-2) expression and synergistically enhances the growth inhibitory effects of trastuzumab (Herceptin™) in breast cancer cells with Her-2/neu oncogene amplification
|
Menendez, J.A.
|
|
|
16 |
3 |
p. 359-371
|
artikel
|
| 20 |
Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial
|
Westermann, A.M.
|
|
|
16 |
3 |
p. 513
|
artikel
|
| 21 |
Phase I–II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer
|
Ohe, Y.
|
|
|
16 |
3 |
p. 430-436
|
artikel
|
| 22 |
Prevention of chemotherapy-induced hair loss by scalp cooling
|
Grevelman, E.G.
|
|
|
16 |
3 |
p. 352-358
|
artikel
|
| 23 |
Prognostic factors in advanced synovial sarcoma: an analysis of 104 patients treated at the Royal Marsden Hospital
|
Spurrell, E.L.
|
|
|
16 |
3 |
p. 437-444
|
artikel
|
| 24 |
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy
|
Arriagada, R.
|
|
|
16 |
3 |
p. 389-396
|
artikel
|
| 25 |
Reply to “Letter to the Editor on ‘Oral ibandronate for the treatment of metastatic bone disease in breast cancer: efficacy and safety results from a randomized, double-blind, placebo-controlled trial”’, by A. M. Westermann doi:10.1093/annonc/mdi072
|
Tripathy, D
|
|
|
16 |
3 |
p. 513
|
artikel
|
| 26 |
Sequential high-dose chemotherapy protocol for relapsed poor prognosis germ cell tumors combining two mobilization and cytoreductive treatments followed by three high-dose chemotherapy regimens supported by autologous stem cell transplantation. Results of the phase II multicentric TAXIF trial
|
Lotz, J.-P.
|
|
|
16 |
3 |
p. 411-418
|
artikel
|
| 27 |
Sequential mitoxantrone/prednisone followed by docetaxel/estramustine in patients with hormone refractory metastatic prostate cancer: results of a phase II study
|
Font, A.
|
|
|
16 |
3 |
p. 419-424
|
artikel
|
| 28 |
Table of Contents
|
|
|
|
16 |
3 |
p. ii-iii
|
artikel
|
| 29 |
Tobacco and Public Health: Science and Policy
|
Hansen, H.H.
|
|
|
16 |
3 |
p. 520
|
artikel
|
| 30 |
Trends in cancer mortality in the Americas, 1970–2000
|
Bosetti, C.
|
|
|
16 |
3 |
p. 489-511
|
artikel
|
| 31 |
Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease
|
Garipidou, V.
|
|
|
16 |
3 |
p. 514-515
|
artikel
|
Tijdschrift beschrijving